MNO-163

N/A

Report date: 2022/06/22 16:53:36

Base Information

Drug NameMNO-163
Drug Alias NameMNO-163
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionGastrointestinal microbiome modulators
TargetsUpdating
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMoon (Guangzhou) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMoon (Guangzhou) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A